A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression

Lihua Y. Marmorstein, Alexander V. Kinev, Gordon K.T. Chan, Daniel A. Bochar, Hideo Beniya, Jonathan A. Epstein, Tim J. Yen, Ramin Shiekhattar

Research output: Contribution to journalArticle

114 Scopus citations

Abstract

Germline mutations of the human BRCA2 gene confer susceptibility to breast cancer. Although the function of the BRCA2 protein remains to be determined, murine cells homozygous for BRCA2 inactivation display chromosomal aberrations. We have isolated a 2 MDa BRCA2-containing complex and identified a structural DNA binding component, designated as BRCA2-Associated Factor 35 (BRAF35). BRAF35 contains a nonspecific DNA binding HMG domain and a kinesin-like coiled coil domain. Similar to BRCA2, BRAF35 mRNA expression levels in mouse embryos are highest in proliferating tissues with high mitotic index. Strikingly, nuclear staining revealed a close association of BRAF35/BRCA2 complex with condensed chromatin coincident with histone H3 phosphorylation. Importantly, antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalCell
Volume104
Issue number2
DOIs
StatePublished - Jan 26 2001
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression'. Together they form a unique fingerprint.

  • Cite this

    Marmorstein, L. Y., Kinev, A. V., Chan, G. K. T., Bochar, D. A., Beniya, H., Epstein, J. A., Yen, T. J., & Shiekhattar, R. (2001). A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell, 104(2), 247-257. https://doi.org/10.1016/S0092-8674(01)00209-4